Assessment of potential drug–drug interactions in cancer patients in a tertiary care hospital

The present study shows that cancer patients are relatively at risk for drug-drug interactions. To avoid Adverse Drug Reaction (ADRs), harmful effects, and other undesirable clinical manifestations shown by drug-drug interactions, screening for pDDIs is required.

Authors

Institutions

Publication Details

Journal
Indian Journal of Cancer
Published
2025-04-01
DOI
https://doi.org/10.4103/ijc.ijc_24_23
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of potential drug–drug interactions in cancer patients in a tertiary care hospital

Ananya Biswas, Prasanna R. Deshpande, Esha Nambiar
4 links
Indian Journal of Cancer
Pharmaceutical Practices and Patient Outcomes
article

Assessment of potential drug–drug interactions in cancer patients in a tertiary care hospital

Ananya Biswas, Prasanna R. Deshpande, Esha Nambiar
article en

Abstract

The present study shows that cancer patients are relatively at risk for drug-drug interactions. To avoid Adverse Drug Reaction (ADRs), harmful effects, and other undesirable clinical manifestations shown by drug-drug interactions, screening for pDDIs is required.

Indian Journal of CancerVol. 62(2)
Shri Vile Parle Kelavani Mandal (IN), Bharati Vidyapeeth (Deemed to be University) (IN)
Openalex Percentile: Top 76%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.